New shot aims to halt migraines Mid-Attack
NCT ID NCT06628921
Summary
This study is testing whether an intravenous medication called eptinezumab can stop a migraine attack while it is happening. The research involves 50 people who experience frequent migraines and are already scheduled to receive eptinezumab as part of their regular care. Doctors will give the medication during an active migraine attack and measure how quickly the pain and other symptoms go away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Campus Biomedico
RECRUITINGRoma, Italy
Contact
Conditions
Explore the condition pages connected to this study.